Generics
ScinoPharm Taiwan secures first US FDA approval for complex multiple sclerosis generic
5 January 2026 - Taiwanese pharmaceutical company ScinoPharm Taiwan (TWSE: 1789) said on Monday that it has received US Food and Drug Administration approval for its Glatiramer Acetate Injection for t...
ScinoPharm Taiwan's Glatiramer Acetate Injection approved by US FDA
5 January 2026 - ScinoPharm Taiwan Ltd (TWSE:1789), a process R&D and API manufacturing service provider to the global pharmaceutical industry, announced on Monday that it has received approval fr...
International Isotopes Inc to change name to Radnostix Inc
2 January 2026 - International Isotopes Inc (INIS) (OTCQB:INIS), a US supplier of generic sodium iodide I-131 radio-pharmaceutical drug products for hyperthyroidism and thyroid cancer, announced on We...
Accord Healthcare launches Clomiphene tablets in US market
3 December 2025 - Generic pharmaceutical company Accord Healthcare Inc, part of India-based Intas Pharmaceuticals, announced on Tuesday that it has launched Clomiphene tablets, the generic equivalent ...
Zentiva receives ESG Transparency Award 2025
1 December 2025 - Zentiva, a Czechia-based generics pharmaceutical company, announced on Friday that it has received the ESG Transparency Award 2025, presented by German market research organisation E...
Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin
18 November 2025 - Clinical-stage biopharmaceutical company Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) on Monday announced results from its joint research with Virginia Commonwealth University (VCU) eva...